MCTS1
Malignant T-cell-amplified sequence 1
Also known as: MCT-1, MCTS1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULC4
- Gene
- MCTS1
- Ensembl
- ENSG00000232119
- Chromosome
- X
- Canonical length
- 181 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
Enables RNA cap binding activity; ribosomal small subunit binding activity; and translation factor activity, non-nucleic acid binding. Involved in IRES-dependent viral translational initiation; cytoplasmic translational initiation; and ribosome disassembly. Is active in cytoplasm. Implicated in immunodeficiency 118. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
181 residues, UniProt reviewed canonical sequence.
>Q9ULC4|MCTS1
1 MFKKFDEKEN VSNCIQLKTS VIKGIKNQLI EQFPGIEPWL NQIMPKKDPV KIVRCHEHIE
61 ILTVNGELLF FRQREGPFYP TLRLLHKYPF ILPHQQVDKG AIKFVLSGAN IMCPGLTSPG
121 AKLYPAAVDT IVAIMAEGKQ HALCVGVMKM SAEDIEKVNK GIGIENIHYL NDGLWHMKTY
181 KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MCTS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 21 nTPM
- liver: 19 nTPM
- cerebral cortex: 19 nTPM
- esophagus: 17 nTPM
- hippocampal formation: 16 nTPM
- kidney: 16 nTPM
Single-cell type
- esophageal apical cells: 233 nCPM
- extravillous trophoblasts: 192 nCPM
- esophageal suprabasal cells: 153 nCPM
- decidual stromal cells: 133 nCPM
- hofbauer cells: 131 nCPM
- late spermatids: 126 nCPM
Immune cell
- plasmacytoid DC: 8.4 nTPM
- myeloid DC: 6.5 nTPM
- memory B-cell: 6.2 nTPM
- T-reg: 6.1 nTPM
- intermediate monocyte: 5.9 nTPM
- non-classical monocyte: 5.9 nTPM
Brain region
- hypothalamus: 8.1 nTPM
- hippocampal formation: 8 nTPM
- cerebral cortex: 7.4 nTPM
- white matter: 7.3 nTPM
- cerebellum: 7.2 nTPM
- basal ganglia: 7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MCTS1.
Disease | AllUniProt
Conditions MCTS1 is implicated in, by any mechanism.
- Immunodeficiency 118 (IMD118) MIM:301115
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 59 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency 118
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.87
- gnomAD missense Z
- 2.05
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA damage response
- formation of translation preinitiation complex
- IRES-dependent viral translational initiation
- ribosome disassembly
- translation reinitiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MCTS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MCTS1 as an antibody target. Whether an autoantibody or antibody against MCTS1 could matter depends on whether native MCTS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MCTS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MCTS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...